Epidemiologic investigations have shown cumulative incidence rates of 10% to 25% 3 , crude mortality rates of 10% to 40% 4 and attributable mortality rates of 5% to 27% 5 . Hospital length of stay and cost are both increased in patients who develop ventilatorassociated pneumonia 6 .
The predominant organisms responsible for infection are Staphylococcus aureus Pseudomonas aeruginosa and Enterobacteriaceae but etiologic agents widely differ according to the population of patients in an intensive care unit duration of hospital stay and prior antimicrobial therapy. Because appropriate antimicrobial treatment of patients with VAP significantly improves outcome more rapid . identification of infected patients and accurate selection of antimicrobial agents represent important clinical goals 7 .
Organisms causing ventilator-associated pneumonia generally fall into two groups: those causing earlyonset ventilator-associated pneumonia (<4 days of mechanical ventilation) and those causing late-onset ventilator-associated pneumonia (>4 days of mechanical ventilation) 3 . Early-onset organisms are typically antibiotic-susceptible community-acquired bacteria, while late-onset organisms are commonly antibiotic-resistant nosocomial organisms. Colonization of the oropharynx and the stomach with potentially pathogenic organisms precedes the development of ventilator-associated pneumonia in most patients. The pathogenesis of ventilatorassociated pneumonia probably involves microaspiration of oropharyngeal or gastric secretions contaminated with these organisms 4 .
The most widely studied preventive strategies have focused on the prevention of oropharyngeal or gastric colonization and the prevention of aspiration of contaminated oropharyngeal or gastric secretions 8 . This evidence-based systematic review aims to identify interventions for the prevention of ventilatorassociated pneumonia, critically evaluate their efficacy and adverse effects and recommend an approach to their use.
The diagnosis of VAP is usually based on three components: systemic signs of infection, new or worsening infiltrates seen on the chest roentgenogram and bacteriologic evidence of pulmonary parenchymal infection 9 . The systemic signs of infection such as fever, tachycardia and leukocytosis are nonspecific findings and can be caused by any condition that releases cytokines 10 . In trauma and other surgical patients, fever and leukocytosis should prompt the physician to suspect infection but during the early post traumatic or postoperative period (i.e., during the first 72 hours) these findings usually are not conclusive. However, later, fever and leukocytosis are more likely to be caused by infection but even then other events associated with an inflammatory response (e.g., devascularized tissue, open wounds, pulmonary edema and/or infarction) can be responsible for these findings.
Aim of our study was to identify the organisms associated with ventilator associated pneumonia (VAP) and to compare our study with other international studies.
Method:
This observational study on ventilator associated pneumonia (VAP) was conducted at Square Hospitals Ltd. Dhaka during April 2007 to March 2009. The aim of the study was to determine the organisms associated with the disease.
Any ventilated patient who developed clinical pneumonia along with culture positive aspirated tracheal fluid constituted VAP. Clinical pneumonia was defined as inflammation of one or both lungs with consolidation which is frequently but not always due to infection. The infection may be bacterial, viral, fungal or parasitic. Symptoms may include fever, chills, cough with sputum production, chest pain, and shortness of breath.
Patients who developed other infections along with VAP and patients who underwent tracheostomy were excluded from the study.
Any ventilated patient who developed fever or respiratory distress was clinically assessed by attending physician. This includes time of developing fever after intubation, Physical examination findings (auscultation findings, pattern of temperature) and chest X-ray findings. On the day of onset of fever or respiratory distress tracheal aspiration was done and the aspirated fluid was sent to microbiology lab for culture and sensitivity test. If bacteria were isolated in culture, the patient was evaluated to asses whether the patient fell under case definition of VAP. If patient was designated to be suffering from VAP all relevant information was documented in a structured questionnaire.
At the end of the data collection period all the questionnaires were complied and a master sheet was made.
Results:
This is an observational analytical cross-sectional study of 'Organisms responsible for ventilator associated pneumonia (VAP) in different department of Hospital'. All the patients diagnosed as VAP was included in this study. Total number of cases was 79. Among these patients 21 patients died which was 26.5 % of the whole series. Study period was 2 years. Total 534 patients died in this hospital during this 2 years period. Death for VAP was 4 % of the total death of the hospital.
Among the 79 VAP patients 52 patients (66%) was male and 27 patients was female. Male : Female ratio was 1.9 : 1. 
Discussion:
We have performed our study on "Organisms associated with ventilator associated pneumonia (VAP) in intensive care unit (ICU)". This was an observational analytic cross section study. Total number of patients was 79. Main objective of our study was to identify the organisms associated with VAP (Ventilator Associated Pneumonia) in intensive care unit (ICU). All patients were diagnosed on the basis of their clinical features, radiological findings and tracheal swab culture sensitivity. Age, sex, time of onset of VAP after intubation, primary diagnosis of patient, isolated organisms and clinical status at the time of discharge was documented as variable in data collection sheet. After collection of data we have tabulated the result and compared with that of international studies.
According to the study of Kollef et al 15.5 % of their ICU patient had developed VAP 11 . Common primary diagnosis of VAP was cardiothoracic (21.6%) and medical disease (9.3%). Mortality rate was 37.2% in their series. In our study we found primary diagnosis of cardiac origin was in 12.6% cases and that of medicine origin was in 34% cases. Mortality was 26.5% in our series.
Kimberly et al. found mortality of VAP in between 20% -50% in their study 12 . In our study mortality rate was 26.5%.
Marin et al. had their study on VAP. According to their study primary diagnosis of VAP was post surgery (15.6%), neurologic disease (13.3%), sepsis (13.1%) and cardiac (10.8%) 13 . In our study primary diagnosis was surgical in 10%, neurological in 28% and cardiac in 12.6%. According to their study duration of developing VAP after intubation was 7.3 days. In our study mean was 8.3 days. Marin We found mortality 26.5% in our study. Staphylococcus aureas (10%) and Pseudomonas aeruginosa (35%) were also common in our series. Donald E et al. performed their epidemiological study on VAP. According to their study rate of VAP increases 6 to 21 fold for intubated patients in ICU 15 . They found the rate of the occurrence of VAP was higher in surgical patients then the medical patients. In our study percentage of medical cases (34%) was more than that of surgical cases (10%).
According to the study of Bonten et al. primary cause of VAP was COPD, ARDS, head injury and trauma in most of the patients 16 . In our study we found primary diagnosis was neurosurgical, medical and surgical in most of the patients. Bonten et al found that maximum number of their patient developed VAP after 5 days of intubation. In our study mean time was 8.3 days to develop VAP.
Shaw et al. found
Staphylococcus aureas as commonest organism in VAP cases of their series 17 . Other common organisms were Pseudomonas aeruginosa and Acinatobacter baumanii. In our study commonest organism was Pseudomonas aeruginosa (35%) followed by Acinetobacter (29%) and Klebsiella (16.3%).
Mortality of VAP patients was 37% in the study of Rakshit et al. In their study male was 56.9% and female was 43.1%. We found mortality 26.5% in our study 18 . Male was 55% in our study where as female was 45%. Rakshit et al. found commonest organism Pseudomonas aeruginosa in their study followed by Klebsiella pneumonae. We also found Pseudomonas spp. commonest organism in our series.
Conclusion:
Pseudomonas spp was the commonest among identified organisms with ventilator associated pneumonia and medicine department having maximum number of VAP patients and compared our results with those of international studies we found similarity in organisms, primary diagnosis and mortality.
